Growth Metrics

Insulet (PODD) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.72%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.10%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.43%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 58.74%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 26.49%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 5.98%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 56.37%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 56.37%
Dec 31, 2025 79.26%
Sep 30, 2025 159.62%
Jun 30, 2025 38.21%
Mar 31, 2025 7.72%
Dec 31, 2024 49.61%
Sep 30, 2024 83.38%
Jun 30, 2024 110.07%
Dec 31, 2023 97.40%
Sep 30, 2023 60.20%
Jun 30, 2023 21.03%
Mar 31, 2023 137.13%
Dec 31, 2022 46.20%
Sep 30, 2022 -115.44%
Jun 30, 2022 -200.00%
Mar 31, 2022 78.78%
Dec 31, 2021 36.25%
Sep 30, 2021 81.71%
Jun 30, 2021 -131.04%
Dec 31, 2020 -29.40%
Sep 30, 2020 86.63%
Jun 30, 2020 54.56%
Mar 31, 2020 43.91%
Dec 31, 2019 35.72%
Sep 30, 2019 30.06%
Jun 30, 2019 31.04%
Mar 31, 2019 33.30%
Dec 31, 2018 33.03%
Sep 30, 2018 27.93%
Jun 30, 2018 53.58%
Mar 31, 2018 15.14%
Dec 31, 2017 -6.27%
Sep 30, 2017 40.51%
Jun 30, 2017 37.40%
Mar 31, 2017 -15.62%
Dec 31, 2016 -58.74%
Sep 30, 2016 49.58%
Jun 30, 2016 26.32%
Mar 31, 2016 1.70%
Dec 31, 2015 -31.73%
Sep 30, 2015 -7.17%
Jun 30, 2015 0.00%
Mar 31, 2015 16.57%
Dec 31, 2014 30.66%
Sep 30, 2014 13.15%
Jun 30, 2014 -46.09%
Mar 31, 2014 20.63%
Dec 31, 2013 56.91%
Sep 30, 2013 -9.14%
Jun 30, 2013 17.79%